EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update
Josef S Smolen, Robert Landewé, J. W. J. Bijlsma, Gerd Burmester, Katerina Chatzidionysiou, Maxime Dougados, Jackie Nam, Sofía Ramiro, Marieke Voshaar, Ronald van Vollenhoven, Daniel Aletaha, Aringer Martin · 2017
Read EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update by Josef S Smolen, Robert Landewé, J. W. J. Bijlsma, Gerd Burmester, Katerina Chatzidionysiou, Maxime Dougados, Jackie Nam, Sofía Ramiro, Marieke Voshaar, Ronald van Vollenhoven, Daniel Aletaha, Aringer Martin (2017) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/openalex-w4308769923.txt.
Description
Josef Smolen, Robert Landewé, J. W. J. Bijlsma, and colleagues present the EULAR recommendations for managing rheumatoid arthritis with disease-modifying drugs. The catalogue record lists an earlier update. The preserved sample, though, is the publisher's page for the 2022 update in the Annals of the Rheumatic Diseases. That page gives only citation details and the author list. It has no readable recommendation text, so the guidance itself cannot be summarised from it here.
Catalog record
| CREATOR | Josef S Smolen, Robert Landewé, J. W. J. Bijlsma, Gerd Burmester, Katerina Chatzidionysiou, Maxime Dougados, Jackie Nam, Sofía Ramiro, Marieke Voshaar, Ronald van Vollenhoven, Daniel Aletaha, Aringer Martin |
|---|---|
| YEAR | 2017 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 109 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | OpenAlex / Annals of the Rheumatic Diseases |